{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-041250","form_type":"8-K","ticker":"SRXH","cik":"0001471727","company_name":"SRx Health Solutions, Inc.","filed_at":"2026-09-02T20:47:43+00:00","discovered_at":"2026-09-02T20:49:01.434809+00:00","generated_at":"2026-09-02T20:49:08.226904+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"SRX Global completes senior secured debt investment in CERo up to $11.67M","bullets":["Note consolidates prior convertible notes totaling $5,666,108.77; additional advances up to $6,000,000 for $11,666,108.77 max.","Initial advance of $775,665 funded Aug 27, 2026 for working capital; 10% annual interest (24.99% default).","Maturity Oct 15, 2026; extendable up to four 30-day periods; secured by CERo subsidiary stock and CER-1236 assets, plus guarantee.","CER-1236 Phase 1 CERTAIN-T: six patients dosed, no DLTs in latest cohort; third cohort (1B cells/patient) expands to MDS and myelofibrosis."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-041250","json":"https://secwatch.observer/filing/0001493152-26-041250.json","markdown":"https://secwatch.observer/filing/0001493152-26-041250.md","text":"https://secwatch.observer/filing/0001493152-26-041250.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/0001493152-26-041250-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1471727/000149315226041250/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-02T20:49:08.226904+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}